newsfilter
← Latest News
Business Wire·

Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc.

- Each shareholder is estimated to receive US$1.82 per share plus one CVR per common share - - Transaction expected to close in the first quarter of 2026 - - Additional portfolio monetization efforts continue - -